Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03878732 · ClinicalTrials.gov registry record
Bindex for Osteoporosis Diagnostics
A clinical trial, sponsored by Bone Index Finland.
- Completed
- Registry status
- 293
- Enrollment target
NCT03878732 is a clinical trial that has completed, run by Bone Index Finland. The registered enrollment target is 293 participants.
The verdict
NCT03878732 has completed, sponsored by Bone Index Finland.
- COMPLETED
- Registry status
- 293 participants
- Enrollment target
Study Summary
Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture risk. Among 200 million osteoporotic patients most are diagnosed only after several fractures. Furthermore, the progressively aging population will increase the prevalence of osteoporosis. It is estimated that over 75% of osteoporotic patients are not diagnosed and does not receive treatment for their condition. Bindex ultrasound device has been developed and validated in Caucasian female population. In this study, diagnostic thresholds for density index as determined with Bindex will be evaluated in two different ethnic populations.
Interventions
- DIAGNOSTIC_TEST Bindex measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2020-02-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03878732
The ClinicalTrials.gov registry entry for NCT03878732 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 293 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bone Index Finland, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bindex measurement is the first listed.
NCT03878732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03878732 about?
NCT03878732 is a clinical study titled "Bindex for Osteoporosis Diagnostics". Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture risk. Among 200 million osteoporotic patients most are diagnosed only after several fractures. Furthermore, the progressively aging population will increase the prevalence of osteoporosis. It is estimated that ...
What is the current status of trial NCT03878732?
This trial is currently completed. The enrollment target is 293 participants. The study started on 2019-03-11. Estimated completion is 2020-02-07.
What interventions are being tested in trial NCT03878732?
The interventions under investigation include: Bindex measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03878732?
This trial is sponsored by Bone Index Finland, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.